 |
 |
Emaar IPO yet undersubscribed; Wockhardt withdraws issue
07 February 2008
|
|
|
|
Wockhardt Hospitals plans Rs569 crore investment in hospital projects
21 January 2008
|
|
|
Wockhardt to demerge R&D business
18 January 2008
|
| | |
|
|
Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US
02 January 2008
|
|
|
Wockhardt
acquires US pharma firm Morton Grove Pharmaceuticals
24 October 2007
|
|
|
Wockhardt
gets US FDA nod to enter the $2.6 billion Norvasc market
17 September 2007
|
|
|
Wockhardt acquires France`s Negma Labs for Rs1,090 crore
03 May 2007
|
|
|
Internal accruals to fund Negma acquisition: Khorakiwala
03 May 2007
|
|
|
Wockhardt to launch Italy''s B-Lift range of dermatology
products in India
23 April 2007
|
|
|
Wockhardt to introduce treatment for dermatological
scars
17 April 2007
|
|
|
The bigger picture
04 April 2007
|
|
|
What the benefactors say
04 April 2007
|
|
|
Wockhardt receives US FDA approval for diuretic injection
28 March 2007
|
|
|
Healthcare industry demands deeper reforms
28 February 2007
|
|
|
Wockhardt signs in-licensing pact with Crawford Healthcare of UK
22 January 2007
|
|
|
Wockhardt, Dr Reddy's launch generic Ondansetron in the US
27 December 2006
|
|
|
FDA orders withdrawal of Wockhardt's insulin brand 'Wosulin'
25 November 2006
|
|
|
Wockhardt Q3 net up 14 per cent at Rs74 crore, sales up 22 per cent at Rs438 crore
26 October 2006
|
|
|
Wockhardt acquires Pinewood for $150 million, fourth European acquisition
03 October 2006
|
|
|
Wockhardt to upgrade and manage hospital in Rajkot
20 September 2006
|
|
|
Wockhardt to develop SEZ near Aurangabad for its global biopharma hub
18 September 2006
|
|
|
Wockhardt close to acquiring Pinewood: CNBC
13 September 2006
|
|
|
Wockhardt's Cefotaxime injection receives US FDA approval
31 August 2006
|
|
|
Wockhardt acquires Dumex with Protinex, Farex brands from Royal Numico NV
30 June 2006
|
|
|
Wockhardt UK expanding Byetta manufacturing capacity
16 June 2006
|
|
|
Wockhardt gets US FDA approval for anti-epilepsy drug
14 June 2006
|
|
|
Wockhardt in-licenses dermatology drug from LSI of UK
05 June 2006
|
|
|
Wockhardt receives US FDA approval for clarithromycin tablets
01 June 2006
|
|
|
US FDA approves Wockhardt's Waluj plant
11 May 2006
|
|
|
Huzaifa
Khorakiwala Dr Murtaza Khorakiwala join Wockhardt board
16 March 2006
|
|
|
Wockhardt to raise up to $800 million to fund overseas acquisitions
16 March 2006
|
|
|
Wockhardt receives US FDA approval for Ranitidine OTC version
27 February 2006
|
|
|
Wockhardt
amongst first to receive US FDA approval for Zonisamide
Capsules
26 December 2005
|
|
|
Wockhardt
becomes South Asia''s first JCI-accredited super-speciality
hospital
11 November 2005
|
|
|
Datamatics appoints H Khorakiwala, Dr Uday Salunkhe as
independent directors
27 October 2005
|
|
|
Wockhardt
becomes only pharmaceutical Superbrand in India
20 July 2005
|
|
|
Wockhardt
joins $billion league
20 July 2005
|
|
|
Wockhardt launches
India''s first automatic insulin delivery device and recombinant insulin
cartridge
17 February 2005
|
|
|
Wockhardt
acquires German firm Esparma
07 May 2004
|
|
|
Wockhardt
Hospital wins excellence in communications awards
26 March 2004
|
|
|
Human
touch for humanity
05 September 2003
|
|
|
Wockhardt
buys CP Pharma
10 July 2003
|
|
|
There
is no plan to sell Vitamin B12 business, says Wockhardt
24 June 2003
|
|
|
Harvard
Medical International, Wockhardt honour five doctors
17 February 2003
|
|
|
Wockhardt
in talks with Watson
24 December 2001
|
|
|
Pharma
companies in talks with MIDC
13 December 2001
|
|
|
Leading
firms, Specialty Ranbaxy tie up
01 December 2001
|
|
|
Wockhardt files investigational application
15 November 2001
|
|
|
Drug
prices revised, Wockhardt to gain
13 August 1999
|
|
|
Wockhardt preparing for
competition
27 April 1999
|
|
|
Wockhardt to separate non-pharma
business
23 April 1999
|
|
|
Wockhardt sets Rs 70-crore
target for nutrition business
22 April 1999
|
|
|
The
story so far
01 January 1900
|
|
|
What
Wockhardt did
01 January 1900
|
